Comparing of the PK, PD, Safety and Immunogenicity of HS-20090 and Xgeva® in Healthy Adults
Clinical trial NCT05777109 · UNKNOWN
Trial details
- NCT number
- NCT05777109
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-20
- Primary completion
- 2024-04-05
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.